Karydas Daphne
SEC insider (Form 3/4/5 filer). CIK 0001816952. Director at Mineralys Therapeutics, Inc. (MLYS) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in RADNOR, PA.
Companies Karydas Daphne has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Director
- COMPASS Pathways plc (CMPS): Director
Karydas Daphne
CIK: 0001816952
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 15, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect3K shares at avg. $12.02$36K - Sep 15, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect3K shares at avg. $28.58$86K - Jun 17, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect3K shares at avg. $25.00$75K - Jun 17, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect3K shares at avg. $12.02$36K - May 27, 2026CMPS
COMPASS Pathways plc
AwardDirectShare Option (Right to Buy)
21.1K shares- - Mar 31, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect3K shares at avg. $12.02$36K - Mar 31, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect3K shares at avg. $25.00$75K - Feb 19, 2026MLYS
Mineralys Therapeutics, Inc.
AwardDirect6.2K shares- - Nov 13, 2025MLYS
Mineralys Therapeutics, Inc.
SaleDirect10.1K shares at avg. $45.81$463K - Nov 13, 2025MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect15K shares at avg. $10.20$153K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  MLYS Mineralys Therapeutics, Inc. | Exercise | 3,000 | $12.02 | $36,060 | Direct |
| Sep 15, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 3,000 | $28.58 | $85,740 | Direct |
| Jun 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 3,000 | $25.00 | $75,000 | Direct |
| Jun 17, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 3,000 | $12.02 | $36,060 | Direct |
| May 27, 2026 |  CMPS COMPASS Pathways plc | Award Share Option (Right to Buy) | 21,110 | - | - | Direct |
| Mar 31, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 3,000 | $12.02 | $36,060 | Direct |
| Mar 31, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 3,000 | $25.00 | $75,000 | Direct |
| Feb 19, 2026 | MLYS Mineralys Therapeutics, Inc. | Award | 6,200 | - | $0 | Direct |
| Nov 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Sale | 10,115 | $45.81 | $463,351 | Direct |
| Nov 13, 2025 | MLYS Mineralys Therapeutics, Inc. | Exercise | 15,000 | $10.20 | $153,000 | Direct |
1-10 of 13 transactions